Most of the genes are prognostic marker of renal cancer, whereas some of them such as BTG2, CD24, OLFM4, and BACE2 are specific to females, i.e., breast cancer and cervical cancer, and MYB specific to males, i.e., prostate cancer (Supp. This evidence concerns the gene BTG2 and Familial prostate cancer.